background genes on the negative selection of imma-
Results or whether the same phenotype could be demonstrated ex vivo. In a previous study (Gonzalez et al., 1997), we found no differences between adult BDC2.5/B6g7 and Defective Clonal Deletion in Fetal and Neonatal BDC2.5/NOD Thymi BDC2.5/NOD thymi, with no overt signs of negative selection on either background. However, it remained For focus and flexibility, we chose to investigate T lymphocyte central tolerance induction in NOD mice by possible that cues for or mechanisms of clonal deletion might be developmentally regulated, so we analyzed using FTOCs. The behavior of thymocytes displaying the BDC2.5 clonotype afforded a convenient and sensithe phenotype of BDC2.5/NOD and BDC2.5/B6g7 mice at late (d18-19) embryonic (not shown) and postnatal tive readout. FTOCs derived from congenic BDC2.5 TCR tg mice of the NOD and C57Bl/6.H2 g7 (B6g7) genetic ( Figure 1B ) stages. Thymi from neonates exhibited phenotypes that paralleled those observed in FTOCs: a backgrounds were compared, permitting a straightforward assessment of influences by non-MHC genetic normal aspect in BDC2.5/NOD thymi, contrasting with a clear imprint of negative selection in BDC2.5/B6g7 loci. This strain combination was particularly suited to our needs because a library of Single Nucleotide Polythymi, with as low as 28% DP thymocytes. Thus, the NOD genetic background appeared to conmorphisms (SNPs) distinguishing the NOD and B6 strains has already been established, and because genetic infer resistance to clonal deletion in differentiating thymocytes that express the BDC2.5 specificity. Non-tg littervals associated with strain-dependent differences in diabetes susceptibility (Idds) have been defined.
termates were analyzed in order to confirm that the different profiles resulted from specific deletion of cells Thymic lobes dissected from day 15.5 embryos derived from parallel matings of the BDC2.5/NOD and BDC2.5/ expressing the self-reactive clonotype, rather than from a differential susceptibility of embryonic thymi of the B6g7 lines were cultured as FTOCs for 3-7 days, and the resulting thymocytes were analyzed for CD4/CD8 NOD versus B6.H2 g7 genetic background to the culture conditions. FTOCs and neonatal thymic lobes from profiles by flow cytometry ( Figure 1A , left and center panels). Lobes from the BDC2.5/NOD cultures looked both genetic backgrounds showed a normal representation of thymocyte compartments, in particular healthy quite normal in their high proportion of immature double-positive (DP) thymocytes and predominant se-DP compartments ( Figure 1C) . A difference in the CD4/ CD8 ratios was observed, consistent with the generally lection into the CD4-single-positive (CD4-SP) mature T cell compartment. In contrast, the BDC2.5/B6g7 lobes higher proportion of CD4 + cells in the NOD mouse (Zhang et al., 1994) . showed clear hallmarks of clonal deletion: reduced total thymocyte numbers; a low proportion of DPs, showClonal deletion of thymocytes expressing the BDC2.5 clonotype observed in FTOCs likely reflects ectopic exing reduced expression of CD4; fewer CD4-SPs; and an increased proportion of CD8-SPs. These differences pression in thymic epithelial cells (Kyewski et al., 2002) of low amounts of the BDC2.5 autoAg; this molecule's persisted when CD4/CD8 profiles of cells gated as expressing the BDC2.5 clonotype were plotted ( Figure 1A , expression appears otherwise to be restricted to the pancreas (Bergman and Haskins, 1994). It is conceivright panels).
We then asked whether the deletion-resistant phenoable that BDC2.5/B6g7 FTOCs express more of the BDC2.5 autoAg than do BDC2.5/NOD cultures, thereby type found for BDC2.5/NOD mice was restricted to fetal thymocytes differentiating in an organ culture system providing an explanation of the above results. To evalu- (Figures 2A-2C) . In BDC2.5/B6g7 thymi, DP cells were combinations of genetic background. Independent of whether the stromal cells were of NOD or B6g7 origin, essentially wiped out by the addition of 1 ng/ml peptide, leaving behind only a few double-negative (DN) seeding with BDC2.5/B6g7 T cell precursors recapitulated the deletion-sensitive phenotype (low % DP cells), precursors and CD8-SP cells; the same dose had little effect on BDC2.5/NOD lobes, which required up to 100 while introducing BDC2.5/NOD T precursors yielded cultures that were significantly more resistant to deleng/ml peptide for a comparable degree of depletion. Thus, the different outcomes of the BDC2.5/NOD and tion. Thus, the impaired ability to delete BDC2.5 T cells in thymi of NOD mice resides with the thymocytes BDC2.5/B6g7 FTOCs appeared to reflect a 50-to 100-fold difference in sensitivity to clonal deletion, not in themselves, consistent with observations on the TCR/ neo-self-Ag double-tg system mentioned above (Lethe expression level of autoAg.
The inefficient deletion of self-reactive thymocytes sage et al., 2002). One might predict that this greater propensity to die on the NOD genetic background could stem from either (Tables S2  and S3 ). The %DP and %DN values were chosen as 14.2) ( Figure 6D ), and secondary peaks on Chr1, 7, 11, and 19. Chr3 was calculated to contribute 31.2% of the the main quantitative traits in this analysis because: a) these metrics most clearly and consistently reflected variance under these conditions. For all of these loci, the NOD allele was again found to be associated with the differences between NOD and B6g7 FTOCs ( Figures  2 and 6A) Figure 7C .) Conversely, the bcl2b isoform was upregulated in BDC2.5/NOD relative to BDC2.5/B6g7 ease. However, this is not the only level at which the NOD genome controls the development of autoimmucultures. Another gene that could potentially act as a modifier of negative selection is the protein phosphanity or of autoimmune disease. Autoimmunity is also influenced by peripheral tolerance, governing the ability tase ptprv, which might modulate TCR signals and was overexpressed in FTOCs of NOD genetic background, of the autoreactive repertoire to be activated and/or regulated. Different genes or clusters of genes might, prior to and independent of TCR engagement by agonist. In addition, two uncharacterized ESTs were overto at least some degree, be involved in central and peripheral tolerance phenomena, e.g., the CTLA-4/ICOS expressed in BDC/B6g7.
The associated interval on Chr3 includes or is flanked family of costimulatory molecules does not seem to be involved in the events described here, mapping to a by several Idd regions ( Figure 7A Even though it is implicit from the experimental setthat different signaling pathways may come into play during thymocyte deletion at high and low ligand conup, which entails the same MHC in both BDC2.5/NOD and BDC2.5/B6g7 mice, one should stress that the recentrations (Kishimoto et al., 1998) . The constellation of loci capable of modulating negative selection that sistance to clonal deletion we have explored does not involve the MHC, but other genetic regions. It has been has accumulated in the NOD genome probably reflects the selection pressure applied during the derivation of proposed that the NOD MHC class II isoform A g7 (and its DQ8 homolog in humans) may predispose to autothis inbred strain (Makino et al., 1980) . It also suggests that the Mus species, as a whole, may benefit from immunity through altering the kinetics/specificity of antigen presentation (reviewed in Nepom and Kwok, maintaining a pool of genetic variation able to dampen repertoire attrition through negative selection, perhaps 1998). The phenomenon described here operates in addition to any impact the MHC may have on differential to avoid repertoire "holes" for specificities needed to effectively confront microbial challenges. selection of autoreactive T cells. Interestingly, the deletion-resistant phenotype imparted by the NOD allele appears dominant, which contrasts with the recessive Genomics The broad perspective offered by the microarray and nature of diabetes susceptibility overall in NOD outcrosses.
PCR analyses revealed two main molecular aspects to the NOD strain's resistance to clonal deletion. First, Multiple genetic intervals were implicated in the subphenotype we explored, even though a priori it seemed there was a reduced induction of key molecules of the apoptotic pathway, including Nur77 and Bim. This to be a relatively simple one. Different intervals dominated when endogenous antigen was presented at low dampening extended to many other genes as well: those transcripts most strongly induced by clonal deledoses versus when the TCR was more decisively engaged by higher doses of peptide that was exogetion triggers on the B6g7 background did show a detectable, but weak, increase on the BDC2.5/NOD backnously added. Specifically, the Chr1 interval became less important and the Chr3 interval took precedence.
ground, but the remainder of the response profile was essentially null. Preliminary results suggest that the reSuch a dichotomy is reminiscent of a previous report 
2004). bcl2
As in the multiorgan autoimmune diseases of aireThe classic antiapoptotic gene, bcl2, maps to the implideficient mice and AIRE-defective patients, autoimcated interval on Chr1, and it showed up as upregumune diabetes in NOD mice is (at least partially) rooted lated in NOD FTOCs in our genomic analysis. Over-or in a fundamental defect in T cell central tolerance inunderexpression of Bcl2 per se has not thus far been duction, more specifically in clonal deletion of selftied to thymocyte clonal deletion (Sentman et al., 1991) , reactive thymocytes. Unlike the disease of patients or but it is noteworthy that the B6 versus NOD difference mice with a mutation in AIRE, wherein autoreactive T cells emerge from the thymus because of a defect in detected in our microarray analysis, and confirmed by
